Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-31 @ 6:33 PM
Study NCT ID:
NCT06387056
Status:
RECRUITING
Last Update Posted:
2024-04-26
First Post:
2024-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
Sponsor:
The First Affiliated Hospital of Xiamen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-21
First Submit QC Date:
None
Study First Post Date:
2024-04-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-24
Last Update Post Date:
2024-04-26
Last Update Post Date Type:
ACTUAL